Capecitabine (Cape) versus 5-fluorouracil (5-FU)–based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial.
Article
Hofheinz, R., Wenz, F. K., Post, S., Matzdorff, A., Laechelt, S., Hartmann, J. T., Müller, L., Link, H., Moehler, M. H., Kettner, E., Fritz, E., Hieber, U., Lindemann, H. W., Grunewald, M., Kremers, S., Constantin, C., Hipp, M., Gencer, D., Burkholder, I. and Hochhaus, A. (2011) Capecitabine (Cape) versus 5-fluorouracil (5-FU)–based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. Journal of Clinical Oncology 29 (15_sup), p. 3504.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Clinical Oncology | ||||
| Publisher | AMER SOC CLINICAL ONCOLOGY | ||||
| Place of Publication | ALEXANDRIA | ||||
| Volume | 29 | ||||
| Number of Issue or Book Chapter | 15_sup | ||||
| Page Range | p. 3504 | ||||
| Date | 2011 | ||||
| Date of publication | 19 Dec 2024 11:10 | ||||
| Institutions | Medicine > Lehrstuhl für Strahlentherapie | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 64937 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric